Position in ABBV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,817,025
+$1,164,768 QoQ
Shares Held
35,942
+23.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Larson Financial Group LLC holds $47,576,049 across 18 Drug Manufacturers - General names. ABBV ranks #2 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,014 | $15,648,966 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
35,942 | $7,817,025 | |
| 3 | MRK |
Merck & Co., Inc.
|
59,707 | $7,182,155 | |
| 4 | JNJ |
Johnson & Johnson
|
28,428 | $6,948,940 | |
| 5 | PFE |
Pfizer Inc
|
109,981 | $3,088,266 | |
| 6 | AMGN |
Amgen Inc
|
6,334 | $2,228,617 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
33,017 | $2,002,481 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
12,065 | $1,681,499 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,817,025 | 35,942 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,652,257 | 29,114 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $6,079,314 | 26,256 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,504,811 | 24,269 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,906,748 | 23,419 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $4,246,852 | 23,899 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,714,993 | 18,812 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,766,960 | 16,132 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $972,414 | 5,340 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $439,339 | 2,835 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $377,121 | 2,530 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $268,651 | 1,994 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $320,811 | 2,013 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $286,049 | 1,770 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $235,404 | 1,754 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $733,789 | 4,791 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $854,157 | 5,269 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $735,222 | 5,430 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $620,036 | 5,748 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $74,680 | 663 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $70,992 | 656 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $67,933 | 634 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $54,918 | 627 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $62,638 | 638 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $31,085 | 408 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||